Capital A, a Netherlands-based investor in companies in the Netherlands, Belgium, and Germany, has announced the close of Capital A Fund V, securing €515m of investor commitments. The Fund was oversubscribed and fully allocated in less than two months.
Fund V represents a 40% increase in fund size compared to its predecessor fund, Capital A Fund IV, which closed at €358m in 2023, receiving support from existing and seven new investors across Europe, the US and Asia Pacific, including Fund of Funds, Family Offices, Endowments and Foundations.
Capital A’s healthcare portfolio includes Tromp Medical, the largest independent medical imaging sales, distibution and service organisation of Northwest Europe, in which it acquired a majority stake in 2019, and Netherlands-based integrated healthcare chain TopzorgGroep.
Since becoming an independent firm in 2018, Capital A has achieved a total realised return of 3.8x gross MOIC and over 40% gross IRR across 25 investments.
Capital A was advised on the fundraise by Rede Partners and Jones Day.
Press release: Capital A announces closing of oversubscribed Fund V at… | Capital A
